About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Preimplantation Genetic Testing Market Size, Top Share And Regional Analysis to 2033
Preimplantation Genetic Testing Market

Preimplantation Genetic Testing Market Size, Share & Trends Analysis Report By Procedure Type (Preimplantation Genetic Diagnosis, Preimplantation Genetic Screening), By Technology  (Comparative Genomic Hybridization, Single-Nucleotide Polymorphism, Next-Generation Sequencing, Polymerase Chain Reaction, Validation Biomarkers, Fluorescence in Situ Hybridization), By Product and Service (Instruments , Reagents and Consumables, Software and Services), By Application (Single Gene Disorders, X-Linked Disorders , Aneuploidy, Structural Chromosomal Abnormalities, HLA Typing), By End-users (Hospitals, Diagnostic Labs, and Service Providers , Maternity Centres & Fertility Clinics, Research Laboratories & Academic Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI296DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Preimplantation Genetic Testing Market Introduction
    2. By Procedure Type
      1. Introduction
        1. Procedure Type By Value
      2. Preimplantation Genetic Diagnosis
        1. By Value
      3. Preimplantation Genetic Screening
        1. By Value
    3. By Technology 
      1. Introduction
        1. Technology  By Value
      2. Comparative Genomic Hybridization
        1. By Value
      3. Single-Nucleotide Polymorphism
        1. By Value
      4. Next-Generation Sequencing
        1. By Value
      5. Polymerase Chain Reaction
        1. By Value
      6. Validation Biomarkers
        1. By Value
      7. Fluorescence in Situ Hybridization
        1. By Value
    4. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Instruments 
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Single Gene Disorders
        1. By Value
      3. X-Linked Disorders 
        1. By Value
      4. Aneuploidy
        1. By Value
      5. Structural Chromosomal Abnormalities
        1. By Value
      6. HLA Typing
        1. By Value
    6. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals, Diagnostic Labs, and Service Providers 
        1. By Value
      3. Maternity Centres & Fertility Clinics
        1. By Value
      4. Research Laboratories & Academic Institutes
        1. By Value
    1. Introduction
    2. By Procedure Type
      1. Introduction
        1. Procedure Type By Value
      2. Preimplantation Genetic Diagnosis
        1. By Value
      3. Preimplantation Genetic Screening
        1. By Value
    3. By Technology 
      1. Introduction
        1. Technology  By Value
      2. Comparative Genomic Hybridization
        1. By Value
      3. Single-Nucleotide Polymorphism
        1. By Value
      4. Next-Generation Sequencing
        1. By Value
      5. Polymerase Chain Reaction
        1. By Value
      6. Validation Biomarkers
        1. By Value
      7. Fluorescence in Situ Hybridization
        1. By Value
    4. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Instruments 
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Single Gene Disorders
        1. By Value
      3. X-Linked Disorders 
        1. By Value
      4. Aneuploidy
        1. By Value
      5. Structural Chromosomal Abnormalities
        1. By Value
      6. HLA Typing
        1. By Value
    6. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals, Diagnostic Labs, and Service Providers 
        1. By Value
      3. Maternity Centres & Fertility Clinics
        1. By Value
      4. Research Laboratories & Academic Institutes
        1. By Value
    7. U.S.
      1. By Procedure Type
        1. Introduction
          1. Procedure Type By Value
        2. Preimplantation Genetic Diagnosis
          1. By Value
        3. Preimplantation Genetic Screening
          1. By Value
      2. By Technology 
        1. Introduction
          1. Technology  By Value
        2. Comparative Genomic Hybridization
          1. By Value
        3. Single-Nucleotide Polymorphism
          1. By Value
        4. Next-Generation Sequencing
          1. By Value
        5. Polymerase Chain Reaction
          1. By Value
        6. Validation Biomarkers
          1. By Value
        7. Fluorescence in Situ Hybridization
          1. By Value
      3. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Instruments 
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Single Gene Disorders
          1. By Value
        3. X-Linked Disorders 
          1. By Value
        4. Aneuploidy
          1. By Value
        5. Structural Chromosomal Abnormalities
          1. By Value
        6. HLA Typing
          1. By Value
      5. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals, Diagnostic Labs, and Service Providers 
          1. By Value
        3. Maternity Centres & Fertility Clinics
          1. By Value
        4. Research Laboratories & Academic Institutes
          1. By Value
    8. Canada
    1. Introduction
    2. By Procedure Type
      1. Introduction
        1. Procedure Type By Value
      2. Preimplantation Genetic Diagnosis
        1. By Value
      3. Preimplantation Genetic Screening
        1. By Value
    3. By Technology 
      1. Introduction
        1. Technology  By Value
      2. Comparative Genomic Hybridization
        1. By Value
      3. Single-Nucleotide Polymorphism
        1. By Value
      4. Next-Generation Sequencing
        1. By Value
      5. Polymerase Chain Reaction
        1. By Value
      6. Validation Biomarkers
        1. By Value
      7. Fluorescence in Situ Hybridization
        1. By Value
    4. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Instruments 
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Single Gene Disorders
        1. By Value
      3. X-Linked Disorders 
        1. By Value
      4. Aneuploidy
        1. By Value
      5. Structural Chromosomal Abnormalities
        1. By Value
      6. HLA Typing
        1. By Value
    6. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals, Diagnostic Labs, and Service Providers 
        1. By Value
      3. Maternity Centres & Fertility Clinics
        1. By Value
      4. Research Laboratories & Academic Institutes
        1. By Value
    7. U.K.
      1. By Procedure Type
        1. Introduction
          1. Procedure Type By Value
        2. Preimplantation Genetic Diagnosis
          1. By Value
        3. Preimplantation Genetic Screening
          1. By Value
      2. By Technology 
        1. Introduction
          1. Technology  By Value
        2. Comparative Genomic Hybridization
          1. By Value
        3. Single-Nucleotide Polymorphism
          1. By Value
        4. Next-Generation Sequencing
          1. By Value
        5. Polymerase Chain Reaction
          1. By Value
        6. Validation Biomarkers
          1. By Value
        7. Fluorescence in Situ Hybridization
          1. By Value
      3. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Instruments 
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Single Gene Disorders
          1. By Value
        3. X-Linked Disorders 
          1. By Value
        4. Aneuploidy
          1. By Value
        5. Structural Chromosomal Abnormalities
          1. By Value
        6. HLA Typing
          1. By Value
      5. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals, Diagnostic Labs, and Service Providers 
          1. By Value
        3. Maternity Centres & Fertility Clinics
          1. By Value
        4. Research Laboratories & Academic Institutes
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Procedure Type
      1. Introduction
        1. Procedure Type By Value
      2. Preimplantation Genetic Diagnosis
        1. By Value
      3. Preimplantation Genetic Screening
        1. By Value
    3. By Technology 
      1. Introduction
        1. Technology  By Value
      2. Comparative Genomic Hybridization
        1. By Value
      3. Single-Nucleotide Polymorphism
        1. By Value
      4. Next-Generation Sequencing
        1. By Value
      5. Polymerase Chain Reaction
        1. By Value
      6. Validation Biomarkers
        1. By Value
      7. Fluorescence in Situ Hybridization
        1. By Value
    4. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Instruments 
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Single Gene Disorders
        1. By Value
      3. X-Linked Disorders 
        1. By Value
      4. Aneuploidy
        1. By Value
      5. Structural Chromosomal Abnormalities
        1. By Value
      6. HLA Typing
        1. By Value
    6. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals, Diagnostic Labs, and Service Providers 
        1. By Value
      3. Maternity Centres & Fertility Clinics
        1. By Value
      4. Research Laboratories & Academic Institutes
        1. By Value
    7. China
      1. By Procedure Type
        1. Introduction
          1. Procedure Type By Value
        2. Preimplantation Genetic Diagnosis
          1. By Value
        3. Preimplantation Genetic Screening
          1. By Value
      2. By Technology 
        1. Introduction
          1. Technology  By Value
        2. Comparative Genomic Hybridization
          1. By Value
        3. Single-Nucleotide Polymorphism
          1. By Value
        4. Next-Generation Sequencing
          1. By Value
        5. Polymerase Chain Reaction
          1. By Value
        6. Validation Biomarkers
          1. By Value
        7. Fluorescence in Situ Hybridization
          1. By Value
      3. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Instruments 
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Single Gene Disorders
          1. By Value
        3. X-Linked Disorders 
          1. By Value
        4. Aneuploidy
          1. By Value
        5. Structural Chromosomal Abnormalities
          1. By Value
        6. HLA Typing
          1. By Value
      5. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals, Diagnostic Labs, and Service Providers 
          1. By Value
        3. Maternity Centres & Fertility Clinics
          1. By Value
        4. Research Laboratories & Academic Institutes
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Procedure Type
      1. Introduction
        1. Procedure Type By Value
      2. Preimplantation Genetic Diagnosis
        1. By Value
      3. Preimplantation Genetic Screening
        1. By Value
    3. By Technology 
      1. Introduction
        1. Technology  By Value
      2. Comparative Genomic Hybridization
        1. By Value
      3. Single-Nucleotide Polymorphism
        1. By Value
      4. Next-Generation Sequencing
        1. By Value
      5. Polymerase Chain Reaction
        1. By Value
      6. Validation Biomarkers
        1. By Value
      7. Fluorescence in Situ Hybridization
        1. By Value
    4. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Instruments 
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Single Gene Disorders
        1. By Value
      3. X-Linked Disorders 
        1. By Value
      4. Aneuploidy
        1. By Value
      5. Structural Chromosomal Abnormalities
        1. By Value
      6. HLA Typing
        1. By Value
    6. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals, Diagnostic Labs, and Service Providers 
        1. By Value
      3. Maternity Centres & Fertility Clinics
        1. By Value
      4. Research Laboratories & Academic Institutes
        1. By Value
    7. UAE
      1. By Procedure Type
        1. Introduction
          1. Procedure Type By Value
        2. Preimplantation Genetic Diagnosis
          1. By Value
        3. Preimplantation Genetic Screening
          1. By Value
      2. By Technology 
        1. Introduction
          1. Technology  By Value
        2. Comparative Genomic Hybridization
          1. By Value
        3. Single-Nucleotide Polymorphism
          1. By Value
        4. Next-Generation Sequencing
          1. By Value
        5. Polymerase Chain Reaction
          1. By Value
        6. Validation Biomarkers
          1. By Value
        7. Fluorescence in Situ Hybridization
          1. By Value
      3. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Instruments 
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Single Gene Disorders
          1. By Value
        3. X-Linked Disorders 
          1. By Value
        4. Aneuploidy
          1. By Value
        5. Structural Chromosomal Abnormalities
          1. By Value
        6. HLA Typing
          1. By Value
      5. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals, Diagnostic Labs, and Service Providers 
          1. By Value
        3. Maternity Centres & Fertility Clinics
          1. By Value
        4. Research Laboratories & Academic Institutes
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Procedure Type
      1. Introduction
        1. Procedure Type By Value
      2. Preimplantation Genetic Diagnosis
        1. By Value
      3. Preimplantation Genetic Screening
        1. By Value
    3. By Technology 
      1. Introduction
        1. Technology  By Value
      2. Comparative Genomic Hybridization
        1. By Value
      3. Single-Nucleotide Polymorphism
        1. By Value
      4. Next-Generation Sequencing
        1. By Value
      5. Polymerase Chain Reaction
        1. By Value
      6. Validation Biomarkers
        1. By Value
      7. Fluorescence in Situ Hybridization
        1. By Value
    4. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Instruments 
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Software and Services
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Single Gene Disorders
        1. By Value
      3. X-Linked Disorders 
        1. By Value
      4. Aneuploidy
        1. By Value
      5. Structural Chromosomal Abnormalities
        1. By Value
      6. HLA Typing
        1. By Value
    6. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals, Diagnostic Labs, and Service Providers 
        1. By Value
      3. Maternity Centres & Fertility Clinics
        1. By Value
      4. Research Laboratories & Academic Institutes
        1. By Value
    7. Brazil
      1. By Procedure Type
        1. Introduction
          1. Procedure Type By Value
        2. Preimplantation Genetic Diagnosis
          1. By Value
        3. Preimplantation Genetic Screening
          1. By Value
      2. By Technology 
        1. Introduction
          1. Technology  By Value
        2. Comparative Genomic Hybridization
          1. By Value
        3. Single-Nucleotide Polymorphism
          1. By Value
        4. Next-Generation Sequencing
          1. By Value
        5. Polymerase Chain Reaction
          1. By Value
        6. Validation Biomarkers
          1. By Value
        7. Fluorescence in Situ Hybridization
          1. By Value
      3. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Instruments 
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Software and Services
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Single Gene Disorders
          1. By Value
        3. X-Linked Disorders 
          1. By Value
        4. Aneuploidy
          1. By Value
        5. Structural Chromosomal Abnormalities
          1. By Value
        6. HLA Typing
          1. By Value
      5. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals, Diagnostic Labs, and Service Providers 
          1. By Value
        3. Maternity Centres & Fertility Clinics
          1. By Value
        4. Research Laboratories & Academic Institutes
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Preimplantation Genetic Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Oxford Gene Technology
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc.
    3. SciGene Corporation
    4. Agilent Technologies Inc.
    5. PerkinElmer Inc.
    6. Coopersurgical Inc.
    7. Abbott Laboratories
    8. Illumina Inc.
    9. Natera Inc
    10. Yikon Genomics
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.